Search results
Results from the WOW.Com Content Network
The Geriatric Mental Health Foundation is a not-for-profit, 501(c)3 organization created by the association to promote awareness of geriatric psychiatry, to reduce mental health stigmas, and to educate the public about mental health issues which disproportionately affect the elderly. Additionally, the foundation focuses on prevention of these ...
Geriatric psychology began in 1978 with a spike in interest in mental health and the effects of aging. There was a slow increase in the number of aging adults in the U.S. population. There was a small group of 11 people who met together to talk about late-life mental health needs and the field of geriatrics.
Thus, states should have greater latitude in regulating the content of advertisements for the veracity of their content. Even though commercial advertising and ideological expression are clearly different, advertisements which convey truthful information are worthy of First Amendment protection, and the elimination of deceptive claims serves to ...
Withdrawn at request of NDA originator, "not for reason of safety or efficacy." [8] [9] Astemizole (Hismanal) 1999 US, Malaysia, Multiple nonspecified markets Fatal arrhythmia [2] [3] Azaribine: 1976 US Thromboembolism. [3] Bendazac: 1993 Spain Hepatotoxicity. [3] Benoxaprofen (Oraflex, Opren) 1982 Germany, Spain, UK, US
The second category includes medications that are potentially inappropriate for older people who have certain diseases or disorders because these drugs may exacerbate the specified health problems. The third category includes medications that, although they may be associated with more risks than benefits in general, may be the best choice for a ...
In 2005, the FDA issued a boxed warning regarding the risk of atypical antipsychotics being prescribed among elderly patients with dementia. This advisory was associated with a decrease in use of antipsychotics, especially in elderly patients with dementia. [11]
Other scholars [who?] have argued against psychiatric medication in that significant aspects of mental illness are related to the psyche or environmental factors, but medication works exclusively on a pharmacological basis. Antipsychotics have been associated with decreases in brain volume over time, which may indicate a neurotoxic effect.
Safety and efficacy data have been reviewed extensively by medical regulators (e.g., the US Food and Drug Administration and the European Medicines Agency), the developers of evidence-based national guidelines (e.g., the UK National Institute for Health and Care Excellence and the American Academy of Pediatrics), and government agencies who ...